Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SuperClot
- Development stage
- Unknown
- Lead developer
- MAC's Medical
- Administration
- Topical
01
Overview
SuperClot is an absorbable hemostatic system composed of Absorbable Modified Polysaccharide (AMP) particles derived from purified plant starch. It is designed to control bleeding during surgical procedures or following traumatic injuries. As a medical device, its primary mechanism of action is the rapid absorption of water from blood—up to 1300% of its mass—which concentrates platelets, red blood cells, and coagulation proteins at the site of injury, thereby accelerating the natural physiological clotting cascade. The product is biocompatible, non-pyrogenic, and contains no human or animal-derived components. It is manufactured by MAC's Medical.
- Brand names
- SuperClot
- Other names
- AMP particlesAbsorbable Modified Polysaccharide
Beyond the preview
Go deeper on SuperClot.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SuperClot.